REFERENCES
- Cairo MS, Bishop M. Tumour lysis syndrome: New therapeutic strategies and classification. Br J Haematol. 2004;127:3–11.
- Chen SW, Hwang WS, Tsao CJ, Liu HS, Huang GC. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: A case report and review of the literature. J Clin Pharm Ther. 2005;30:623–625.
- Wright JL, Lin DW, Dewan P, Montgomery RB. Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer. Int J Urol. 2005;12:1012–1013.
- Haas M, Ohler L, Watzke H, Böhmig G, Prokesch R, Druml W. The spectrum of acute renal failure in tumour lysis syndrome. Nephrol Dial Transplant. 1999;14:776–779.
- Mato AR, Riccio BE, Qin L, A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma. 2006;47:877–883.
- Cammalleri L, Malaguarnera M. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci. 2007;4:83–93.
- Agnani S, Gupta R, Atray NK, Vachharajani TJ. Marked hyperuricemia with acute renal failure: Need to consider occult malignancy and spontaneous tumour lysis syndrome. Int J Clin Pract. 2006;60:364–366.
- Hsu HH, Chan YL, Huang CC. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: Clinical features and therapeutic approach. J Nephrol. 2004;17:50–56.
- Ejaz AA, Mu W, Kang DH, Could uric acid have a role in acute renal failure?. Clin J Am Soc Nephrol. 2007;2:16–21.
- Hummel M, Buchheidt D, Reiter S, Bergmann J, Adam K, Hehlmann R. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia-successful treatment and prevention of TLS with low-dose rasburicase. Eur J Haematol. 2005;75:518–521.
- Teo WY, Loh TF, Tan AM. Avoiding dialysis in tumour lysis syndrome: Is urate oxidase effective? – A case report and review of literature. Ann Acad Med Singap. 2007;36:679–683.